Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

C&D Steps Up To The Plate; Signs Baseball Star Giambi To Promote Ultramax

This article was originally published in The Tan Sheet

Executive Summary

Church & Dwight has signed New York Yankees player Jason Giambi as spokesperson for its Arm & Hammer Ultramax antiperspirant/deodorant brand

You may also be interested in...



C&D Organic Growth Initiative To Sprout Oral Care, Antiperspirant Extensions

Church & Dwight is undertaking an aggressive product launch strategy within its oral care and antiperspirant/ deodorant businesses in 2003 as it shifts its focus to internal growth, CEO Robert Davies told analysts during a third quarter financials briefing Nov. 5

C&D Organic Growth Initiative To Sprout Oral Care, Antiperspirant Extensions

Church & Dwight is undertaking an aggressive product launch strategy within its oral care and antiperspirant/ deodorant businesses in 2003 as it shifts its focus to internal growth, CEO Robert Davies told analysts during a third quarter financials briefing Nov. 5

C&D Trojan Retail Sales Rise 6% In Q2, First Response Up 7%

Retail sales for Church & Dwight's Trojan condom business grew 6% in the second quarter, reflecting in part consumers' positive response to recent line extensions, C&D President of Personal Care and Armkel Brad Casper told analysts Aug. 5

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094168

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel